Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

What Were the Top-line Data Results from the LEAP-1 Study?

OCT 06, 2017 | CONTAGION® EDITORIAL STAFF


Steven Gelone, PharmD, chief scientific officer at Nabriva Therapeutics, shares the topline data yielded from the LEAP-1 study.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x